We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EWBC:NASDAQEast West Bancorp, Inc. Analysis

Data as of 2026-04-01 - not real-time

$109.33

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

East West Bancorp is trading at $109.33, which sits just above the 20‑day SMA of $105.79 but below the 50‑day SMA of $112.01, indicating a short‑term pull‑back within a neutral longer‑term trend (200‑day SMA $107.45). The RSI of 53.4 and a bullish MACD histogram (+$0.68) suggest modest upside momentum, while the price remains comfortably above the identified support at $102.27 and near the resistance level of $111.14. Volatility is elevated at 31.7% over the past 30 days and beta exceeds 1, pointing to higher price swings relative to the market. On the fundamentals side, EWBC delivers a solid 21.3% revenue growth, an operating margin of 66%, and a profit margin of 49%, all while trading at a forward PE of 9.98 versus a sector average of 16.5. The stock offers a 3% dividend yield with a low payout ratio of 25%, underscoring dividend sustainability. Valuation metrics show a trailing PE of 11.5 and a price‑to‑book of 1.69, both well below industry norms, and a discounted cash‑flow fair value of $256.21, implying roughly 20% upside to current levels. Analyst consensus is a “Buy” with a mean target of $131.25, reinforced by recent bullish coverage from BofA and Morgan Stanley. Overall, the combination of technical support, attractive valuation gaps, strong earnings quality, and a reliable dividend makes EWBC a compelling near‑term opportunity.
Given the heightened volatility and beta, investors should monitor the $111 resistance and macro‑economic pressures on regional banks, but the long‑term fundamentals and dividend profile support a continued positive outlook.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD histogram and RSI near neutral
  • Price positioned between clear support ($102.27) and resistance ($111.14)
  • Positive analyst upgrades and a 3% dividend yield

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth (21% YoY) and high operating margins
  • Undervalued valuation with ~20% upside to DCF fair value
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Robust cash generation and low leverage
  • Consistent dividend policy supporting income investors
  • Strategic exposure to US‑Asia trade financing driving future earnings

Key Metrics & Analysis

Financial Health

Revenue Growth21.30%
Profit Margin49.13%
P/E Ratio11.5
ROE15.95%
ROA1.69%
P/B Ratio1.7
Op. Cash Flow$1.5B
Industry P/E16.5

Technical Analysis

TrendNeutral
RSI53.4
Support$102.27
Resistance$111.14
MA 20$105.79
MA 50$112.01
MA 200$107.45
MACDBullish
VolumeIncreasing
Fear & Greed Index77.61

Valuation

Fair Value$256.21
Target Price$131.25
Upside/Downside20.05%
GradeUndervalued
TypeValue
Dividend Yield3.00%

Risk Assessment

Beta1.21
Volatility31.68%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.